Last updated on May 2020

Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Rheumatoid Arthritis | Rheumatoid Arthritis (Pediatric)
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • All participants treated with RINVOQ.

Exclusion Criteria:

  • Participants not taking RINVOQ.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.